Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2Phase 2 1

Status

Recruiting 5Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 7Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 7

Conditions

Advanced Solid Tumors 481Solid Tumor 418Advanced Solid Tumor 409Unspecified Adult Solid Tumor, Protocol Specific 350Solid Tumors 322Mesothelioma, Malignant 281Mesothelioma 244Solid Tumor, Adult 113Carcinoma, Non-Small-Cell Lung 109Retinoblastoma 81Ovarian Neoplasms 65Lung Neoplasms 61Melanoma 56Sarcoma 52Stomach Neoplasms 50Carcinoma, Renal Cell 49Colorectal Neoplasms 46Small Cell Lung Carcinoma 45Pancreatic Neoplasms 45Esophageal Neoplasms 45Neoplasms 43Uterine Cervical Neoplasms 41Breast Neoplasms 38Advanced or Metastatic Solid Tumors 35Hematopoietic and Lymphatic System Neoplasm 34Neoplasm Metastasis 33Squamous Cell Carcinoma of Head and Neck 32Advanced Malignant Solid Tumors 31Solid Tumours 30Triple Negative Breast Neoplasms 29

Interventions

Paclitaxel 2Pemetrexed 1Oxaliplatin 1Etoposide 1Drug Therapy 1Docetaxel 1Clinical Trials, Phase II as Topic 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Advanced Solid Tumor Cancer × Other solid neoplasm × Clear all
NCT07455734 2026-05-14

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

BioNTech SE

Phase 1/2 Recruiting
533 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07477743 2026-03-17

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

HC Biopharma Inc.

Phase 1 Recruiting
331 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07446725 2026-03-03

A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors

Suzhou Genhouse Bio Co., Ltd.

Phase 1/2 Not yet recruiting
152 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07387081 2026-02-04

Phase II Study of LM-24C5

LaNova Medicines Limited

Phase 2 Recruiting
130 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07381829 2026-02-02

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

HC Biopharma Inc.

Phase 1 Recruiting
328 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07260513 2025-12-03

GH2616C102

Suzhou Genhouse Bio Co., Ltd.

Phase 1 Active not recruiting
126 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07139067 2025-08-24

YK1101

Peking University

Phase 1 Recruiting
10 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡